Cargando…

Novel Antiviral Strategies in the Treatment of COVID-19: A Review

The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus-2 (SARS–CoV-2), is still a global public health problem for humans. It has caused more than 10,000,000 infections and more than 500,000 deaths in the world so far. Many scientists have tried the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Shiu-Jau, Wang, Shao-Cheng, Chen, Yuan-Chuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569957/ https://www.ncbi.nlm.nih.gov/pubmed/32825283 http://dx.doi.org/10.3390/microorganisms8091259

Ejemplares similares

Antiviral Agents as Therapeutic Strategies Against Cytomegalovirus Infections
por: Chen, Shiu-Jau, et al.
Publicado: (2019)

Challenges, Recent Advances and Perspectives in the Treatment of Human Cytomegalovirus Infections
por: Chen, Shiu-Jau, et al.
Publicado: (2022)

Potential Therapeutic Approaches Against Brain Diseases Associated with Cytomegalovirus Infections
por: Wang, Shao-Cheng, et al.
Publicado: (2020)

The Immunotherapy for Colorectal Cancer, Lung Cancer and Pancreatic Cancer
por: Chen, Shiu-Jau, et al.
Publicado: (2021)

Point-of-Care Testing for Infectious Diseases Based on Class 2 CRISPR/Cas Technology
por: Chen, Shiu-Jau, et al.
Publicado: (2023)

Potential Application of TALENs against Murine Cytomegalovirus Latent Infections
por: Chen, Shiu-Jau, et al.
Publicado: (2019)

Current treatment strategies for COVID-19
por: Han, Fabin, et al.
Publicado: (2021)

Current and Future Direct-Acting Antivirals Against COVID-19
por: Chan, Shiu-Wan
Publicado: (2020)

Narcotic Addiction in Failed Back Surgery Syndrome
por: Chen, Yuan-Chuan, et al.
Publicado: (2018)

Chitosan Nanoparticles for Antiviral Drug Delivery: A Novel Route for COVID-19 Treatment
por: Safer, Abdel-Majed, et al.
Publicado: (2021)

Challenges and Recent Advancements in COVID-19 Vaccines
por: Wang, Shao-Cheng, et al.
Publicado: (2023)

Clinical efficacy of antivirals against novel coronavirus (COVID-19): A review
por: Jomah, Shahamah, et al.
Publicado: (2020)

Comprehensive review on molnupiravir in COVID-19: a novel promising antiviral to combat the pandemic
por: Khiali, Sajad, et al.
Publicado: (2022)

Safety and Efficacy of Antiviral Drugs for the Treatment of COVID-19: A Systematic Review
por: Nie, Zhenwang, et al.
Publicado: (2022)

Oral Antiviral Treatment for COVID-19: A Comprehensive Review on Nirmatrelvir/Ritonavir
por: Akinosoglou, Karolina, et al.
Publicado: (2022)

Efficacy and Safety of Novel Oral Antivirals in Hospitalized COVID-19 Patients: A Network Meta-Analysis of Randomized Clinical Trials
por: Liu, Haoshuang, et al.
Publicado: (2023)

Antivirals for COVID-19: A critical review
por: Frediansyah, Andri, et al.
Publicado: (2021)

Plant lectins as prospective antiviral biomolecules in the search for COVID-19 eradication strategies
por: Ahmed, Md. Nasir, et al.
Publicado: (2022)

Antiviral Drug Discovery for the Treatment of COVID-19 Infections
por: Ng, Teresa I., et al.
Publicado: (2022)

Opioid Addiction, Genetic Susceptibility, and Medical Treatments: A Review
por: Wang, Shao-Cheng, et al.
Publicado: (2019)

Difference in the incidence of cerebrospinal fluid leakage and residual tumors between functional and nonfunctional pituitary adenomas treated by endoscopic transsphenoidal pituitary adenomectomy
por: Lee, Ching-Yi, et al.
Publicado: (2019)

Antiviral Approach to Cytomegalovirus Infection: An Overview of Conventional and Novel Strategies
por: Bottino, Paolo, et al.
Publicado: (2023)

Alcohol Addiction, Gut Microbiota, and Alcoholism Treatment: A Review
por: Wang, Shao-Cheng, et al.
Publicado: (2020)

Antiviral strategies targeting herpesviruses
por: Dong, Haisi, et al.
Publicado: (2021)

Science-Based Strategies of Antiviral Coatings with Viricidal Properties for the COVID-19 Like Pandemics
por: Pemmada, Rakesh, et al.
Publicado: (2020)

Antiviral Efficacy of Molnupiravir for COVID-19 Treatment
por: Bai, Yuan, et al.
Publicado: (2022)

Targeting the Host Mitochondria as a Novel Human Cytomegalovirus Antiviral Strategy
por: Bachman, Lauryn O., et al.
Publicado: (2023)

Antiviral Therapy of COVID-19
por: Gudima, Georgii, et al.
Publicado: (2023)

COVID-19 Antiviral and Treatment Candidates: Current Status
por: Españo, Erica, et al.
Publicado: (2021)

Potential of amentoflavone with antiviral properties in COVID-19 treatment
por: Singh, Akhilesh Vikram
Publicado: (2021)

Antiviral treatment of COVID-19
por: ŞİMŞEK YAVUZ, Serap, et al.
Publicado: (2020)

Gut microbiota in antiviral strategy from bats to humans: a missing link in COVID-19
por: Luo, Jia, et al.
Publicado: (2021)

Update on Antiviral Strategies Against COVID-19: Unmet Needs and Prospects
por: Liu, Ching-Hsuan, et al.
Publicado: (2021)

Current Strategies of Antiviral Drug Discovery for COVID-19
por: Mei, Miao, et al.
Publicado: (2021)

A Focus on the Nowadays Potential Antiviral Strategies in Early Phase of Coronavirus Disease 2019 (Covid-19): A Narrative Review
por: Monari, Caterina, et al.
Publicado: (2020)

Perspective Adjunctive Therapies for COVID-19: Beyond Antiviral Therapy
por: Ho, Ping, et al.
Publicado: (2021)

Advances in the Development of Antiviral Strategies against Parvovirus B19
por: Manaresi, Elisabetta, et al.
Publicado: (2019)

CRISPR-Cas Targeting of Host Genes as an Antiviral Strategy
por: Chen, Shuliang, et al.
Publicado: (2018)

Oral antiviral treatments for COVID-19: opportunities and challenges
por: Rahmah, Laila, et al.
Publicado: (2022)

Antivirals and antiviral strategies
por: Clercq, Erik De
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_0p4a16ck3gv414spdhvgr304n8